TABLE 4.
Absorbed Doses to Target Organs and Effective Dose
| Organ doses (mGy/MBq) | ||
|---|---|---|
| Target organ | 68Ga-NODAGA-LM3 | 68Ga-DOTA-LM3 |
| Adrenals | 0.014 ± 0.001 | 0.014 ± 0.001 |
| Brain | 0.009 ± 0.001 | 0.008 ± 0.002 |
| Breasts | 0.009 ± 0.000 | 0.009 ± 0.001 |
| Gallbladder wall | 0.015 ± 0.001 | 0.017 ± 0.004 |
| Lower large intestine wall | 0.012 ± 0.001 | 0.012 ± 0.002 |
| Small intestine | 0.012 ± 0.001 | 0.013 ± 0.003 |
| Stomach wall | 0.012 ± 0.000 | 0.011 ± 0.001 |
| Upper large intestine wall | 0.012 ± 0.000 | 0.012 ± 0.001 |
| Heart wall | 0.011 ± 0.000 | 0.011 ± 0.001 |
| Kidneys | 0.136 ± 0.061 | 0.064 ± 0.052 |
| Liver | 0.056 ± 0.028 | 0.098 ± 0.075 |
| Lungs | 0.011 ± 0.000 | 0.010 ± 0.001 |
| Muscle | 0.010 ± 0.000 | 0.010 ± 0.001 |
| Ovaries | 0.013 ± 0.001 | 0.012 ± 0.002 |
| Pancreas | 0.015 ± 0.002 | 0.013 ± 0.000 |
| Red marrow | 0.016 ± 0.003 | 0.013 ± 0.003 |
| Osteogenic cells | 0.019 ± 0.002 | 0.016 ± 0.003 |
| Skin | 0.009 ± 0.000 | 0.008 ± 0.001 |
| Testes | 0.010 ± 0.001 | 0.010 ± 0.002 |
| Spleen | 0.132 ± 0.151 | 0.034 ± 0.022 |
| Thymus | 0.010 ± 0.001 | 0.010 ± 0.001 |
| Thyroid | 0.010 ± 0.001 | 0.009 ± 0.001 |
| Urinary bladder wall | 0.162 ± 0.045 | 0.202 ± 0.073 |
| Uterus | 0.015 ± 0.002 | 0.015 ± 0.003 |
| Total body | 0.013 ± 0.000 | 0.013 ± 0.000 |
| Effective dose (mSv/MBq) | 0.026 ± 0.002 | 0.025 ± 0.002 |